A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Liva Nova PLC stock. As of the latest transaction made, Two Sigma Advisers, LP holds 115,245 shares of LIVN stock, worth $6.32 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
115,245
Previous 106,445 8.27%
Holding current value
$6.32 Million
Previous $5.51 Million 17.05%
% of portfolio
0.02%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$48.6 - $57.12 $427,680 - $502,656
8,800 Added 8.27%
115,245 $6.45 Million
Q4 2023

Feb 14, 2024

SELL
$43.45 - $53.66 $1.53 Million - $1.89 Million
-35,300 Reduced 24.9%
106,445 $5.51 Million
Q3 2023

Nov 14, 2023

SELL
$50.12 - $58.87 $4.33 Million - $5.09 Million
-86,400 Reduced 37.87%
141,745 $7.5 Million
Q2 2023

Aug 14, 2023

SELL
$42.28 - $51.43 $794,864 - $966,884
-18,800 Reduced 7.61%
228,145 $11.7 Million
Q1 2023

May 15, 2023

BUY
$40.84 - $58.14 $5.44 Million - $7.74 Million
133,200 Added 117.1%
246,945 $10.8 Million
Q4 2022

Feb 14, 2023

BUY
$43.88 - $56.16 $3.09 Million - $3.96 Million
70,500 Added 163.02%
113,745 $6.32 Million
Q3 2022

Nov 14, 2022

BUY
$48.37 - $66.5 $425,656 - $585,200
8,800 Added 25.55%
43,245 $2.2 Million
Q2 2022

Aug 15, 2022

SELL
$57.25 - $86.63 $1.11 Million - $1.68 Million
-19,400 Reduced 36.03%
34,445 $2.15 Million
Q1 2022

May 16, 2022

SELL
$71.02 - $86.99 $13.8 Million - $16.9 Million
-193,800 Reduced 78.26%
53,845 $4.41 Million
Q4 2021

Feb 14, 2022

SELL
$76.72 - $92.68 $8.93 Million - $10.8 Million
-116,400 Reduced 31.97%
247,645 $21.7 Million
Q3 2021

Nov 15, 2021

BUY
$76.02 - $88.62 $11.9 Million - $13.8 Million
156,200 Added 75.15%
364,045 $28.8 Million
Q2 2021

Aug 16, 2021

BUY
$73.44 - $87.01 $14.5 Million - $17.2 Million
197,400 Added 1889.9%
207,845 $17.5 Million
Q1 2021

May 17, 2021

BUY
$62.9 - $82.41 $656,990 - $860,772
10,445 New
10,445 $770,000
Q3 2020

Nov 16, 2020

SELL
$41.91 - $57.81 $580,243 - $800,379
-13,845 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$39.87 - $56.9 $552,000 - $787,780
13,845 New
13,845 $666,000
Q3 2019

Nov 14, 2019

SELL
$71.74 - $86.35 $1.15 Million - $1.39 Million
-16,045 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$66.45 - $97.36 $1.07 Million - $1.56 Million
16,045 New
16,045 $1.16 Million
Q4 2018

Feb 14, 2019

SELL
$84.14 - $125.42 $825,076 - $1.23 Million
-9,806 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$101.02 - $130.95 $990,602 - $1.28 Million
9,806 New
9,806 $1.22 Million
Q1 2018

May 15, 2018

SELL
$79.95 - $89.74 $1.77 Million - $1.99 Million
-22,146 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$71.8 - $88.21 $344,640 - $423,407
-4,800 Reduced 17.81%
22,146 $1.77 Million
Q3 2017

Nov 14, 2017

BUY
$60.32 - $70.06 $1.63 Million - $1.89 Million
26,946
26,946 $1.89 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.94B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.